<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37757951</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1995-820X</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Virologica Sinica</Title><ISOAbbreviation>Virol Sin</ISOAbbreviation></Journal><ArticleTitle>Structural insight into EV-A71 3A protein and its interaction with a peptide inhibitor.</ArticleTitle><Pagination><StartPage>975</StartPage><EndPage>979</EndPage><MedlinePgn>975-979</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virs.2023.09.004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1995-820X(23)00112-8</ELocationID><Abstract><AbstractText>• Our results disclosed a dihelical structure of Enterovirus A71 3A<sub>1–57</sub> protein in apo form. • We depicted rigid helices and a unique flexible C-terminus for apo-form 3A<sub>1–57</sub>. • This study revealed a competitive binding-based molecular mechanism underlying inhibition of dimeric 3A by ER-DRI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yahui</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology, Wuhan, 430030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Panjing</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology, Wuhan, 430030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Medical Subcenter of HUST Analytical &amp; Testing Center, Huazhong University of Science and Technology, Wuhan, 430030, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jiahai</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>MOE Key Laboratory for Membraneless Organelles and Cellular Dynamics, School of Life Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230027, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Xi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qiu</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Kun</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Institute of Health Inspection and Testing, Hubei Provincial Center for Disease Control and Prevention (Hubei CDC), Wuhan, 430079, China. Electronic address: ckreal@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Haoran</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology, Wuhan, 430030, China. Electronic address: hrzhang@outlook.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fang</LastName><ForeName>Yuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, 430071, China. Electronic address: fangyuan_125@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Huazhong University of Science and Technology, Wuhan, 430030, China; Department of Pediatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. Electronic address: yanli@hust.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Virol Sin</MedlineTA><NlmUniqueID>101514185</NlmUniqueID><ISSNLinking>1995-820X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>26</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>28</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>27</Day><Hour>19</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37757951</ArticleId><ArticleId IdType="pmc">PMC10786657</ArticleId><ArticleId IdType="doi">10.1016/j.virs.2023.09.004</ArticleId><ArticleId IdType="pii">S1995-820X(23)00112-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baggen J., Thibaut H.J., Strating J.R.P.M., van Kuppeveld F.J.M. The life cycle of non-polio enteroviruses and how to target it. Nat. Rev. Microbiol. 2018;16:368–381.</Citation><ArticleIdList><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang Y., Liu Z., Qiu Y., Kong J., Fu Y., Liu Y., Wang C., Quan J., Wang Q., Xu W., Yin L., Cui J., Xu Y., Curry S., Jiang S., Lu L., Zhou X. Inhibition of viral suppressor of RNAi proteins by designer peptides protects from enteroviral infection in vivo. Immunity. 2021;54:2231–2244.e6.</Citation><ArticleIdList><ArticleId IdType="pubmed">34555337</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Q., Yuan S., Zhang C., Wang Ying, Wang Yizhuo, He G., Zhang S., Altmeyer R., Zou G. Discovery of itraconazole with broad-spectrum in vitro antienterovirus activity that targets nonstructural protein 3A. Antimicrob. Agents Chemother. 2015;59:2654–2665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4394834</ArticleId><ArticleId IdType="pubmed">25691649</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan X., Che Y., Wei S., Li S., Zhao Z., Tong Y., Wang L., Gong W., Zhang Y., Zhao Y., Wu Y., Wang S., Jiang R., Huang J., Liu Y., Luo W., Liao Y., Hu X., Zhang W., Dai Y., Jiang G., Min G., Liu F., You X., Xu X., Li J., Li C., Fan S., Hang L., Huang Q., Li Q. Effectiveness and safety of an inactivated enterovirus 71 vaccine in children aged 6–71 months in a phase IV study. Clin. Infect. Dis. 2020;71:2421–2427.</Citation><ArticleIdList><ArticleId IdType="pubmed">31734699</ArticleId></ArticleIdList></Reference><Reference><Citation>Horova V., Lyoo H., Różycki B., Chalupska D., Smola M., Humpolickova J., Strating J.R.P.M., van Kuppeveld F.J.M., Boura E., Klima M. Convergent evolution in the mechanisms of ACBD3 recruitment to picornavirus replication sites. PLoS Pathog. 2019;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6695192</ArticleId><ArticleId IdType="pubmed">31381608</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones E., Pillay T.D., Liu F., Luo L., Bazo-Alvarez J.C., Yuan C., Zhao S., Chen Q., Li Y., Liao Q., Yu H., Rogier van Doorn H., Sabanathan S. Outcomes following severe hand foot and mouth disease: a systematic review and meta-analysis. Eur. J. Paediatr. Neurol. 2018;22:763–773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6148319</ArticleId><ArticleId IdType="pubmed">29778429</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh W.M., Badaruddin H., La H., Chen M.I.C., Cook A.R. Severity and burden of hand, foot and mouth disease in Asia: a modelling study. BMJ Glob. Health. 2018;3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5859810</ArticleId><ArticleId IdType="pubmed">29564154</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim H.X., Poh C.L. Insights into innate and adaptive immune responses in vaccine development against EV-A71. Ther. Adv. Vaccines Immunother. 2019;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6873268</ArticleId><ArticleId IdType="pubmed">31799495</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J.Y., Brewer G., Li M.L., Lin K.Z., Huang C.C., Yen L.C., Lin J.Y. Secretory carrier membrane protein 3 interacts with 3A viral protein of enterovirus and participates in viral replication. Microbiol. Spectr. 2021;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8552740</ArticleId><ArticleId IdType="pubmed">34378951</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandary M.B., Poh C.L. Changes in the EV-A71 genome through recombination and spontaneous mutations: impact on virulence. Viruses. 2018;10:320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6024729</ArticleId><ArticleId IdType="pubmed">29895721</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Q., Wang Y., Bian L., Xu M., Liang Z. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD) Expert Rev. Vaccines. 2016;15:599–606.</Citation><ArticleIdList><ArticleId IdType="pubmed">26732723</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P.C. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 2002;26:91–107.</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasri D., Bouslama L., Pillet S., Bourlet T., Aouni M., Pozzetto B. Basic rationale, current methods and future directions for molecular typing of human enterovirus. Expert Rev. Mol. Diagn. 2007;7:419–434.</Citation><ArticleIdList><ArticleId IdType="pubmed">17620049</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T.T., Chiu C.H., Lin C.Y., Chiu N.C., Chen P.Y., Le T.T.V., Le D.N., Duong A.H., Nguyen V.L., Huynh T.N., Truong H.K., Phan T.L., Nguyen T.T.T., Shih S.R., Huang C.G., Weng Y.J., Hsieh E.F., Chang S., Chen C., Tai I.C., Huang L.M. Efficacy, safety, and immunogenicity of an inactivated, adjuvanted enterovirus 71 vaccine in infants and children: a multiregion, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet. 2022;399:1708–1717.</Citation><ArticleIdList><ArticleId IdType="pubmed">35427481</ArticleId></ArticleIdList></Reference><Reference><Citation>Norder H., De Palma A.M., Selisko B., Costenaro L., Papageorgiou N., Arnan C., Coutard B., Lantez V., De Lamballerie X., Baronti C., Solà M., Tan J., Neyts J., Canard B., Coll M., Gorbalenya A.E., Hilgenfeld R. Picornavirus non-structural proteins as targets for new anti-virals with broad activity. Antiviral Res. 2011;89:204–218.</Citation><ArticleIdList><ArticleId IdType="pubmed">21236302</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi M.H., Wong S.C., Lewthwaite P., Cardosa M.J., Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9:1097–1105.</Citation><ArticleIdList><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu Y., Xu Y., Zhang Y., Zhou H., Deng Y.Q., Li X.F., Miao M., Zhang Q., Zhong B., Hu Y., Zhang F.C., Wu L., Qin C.F., Zhou X. Human virus-derived small RNAs can confer antiviral immunity in mammals. Immunity. 2017;46:992–1004.e5.</Citation><ArticleIdList><ArticleId IdType="pubmed">28636969</ArticleId></ArticleIdList></Reference><Reference><Citation>Rattanakomol P., Srimanote P., Tongtawe P., Khantisitthiporn O., Supasorn O., Thanongsaksrikul J. Host neuronal PRSS3 interacts with enterovirus A71 3A protein and its role in viral replication. Sci. Rep. 2022;12:12846.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9328647</ArticleId><ArticleId IdType="pubmed">35896602</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi P., Swapna G.V.T., Huang Y.J., Aramini J.M., Anklin C., Conover K., Hamilton K., Xiao R., Acton T.B., Ertekin A., Everett J.K., Montelione G.T. A microscale protein NMR sample screening pipeline. J. Biomol. NMR. 2010;46:11–22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2797623</ArticleId><ArticleId IdType="pubmed">19915800</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Z., Liang Y., Chen Z., Yin J., Li C., Pan P., Zhang Q., Wu J., Luo Z. Enterovirus 71 non-structural protein 3A hijacks vacuolar protein sorting 25 to boost exosome biogenesis to facilitate viral replication. Front. Microbiol. 2022;13:1024899.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9581156</ArticleId><ArticleId IdType="pubmed">36274707</ArticleId></ArticleIdList></Reference><Reference><Citation>Salonen A., Ahola T., Kääriäinen L. In: Membrane Trafficking in Viral Replication. Marsh M., editor. Springer Berlin Heidelberg; Berlin, Heidelberg: 2005. Viral RNA replication in association with cellular membranes; pp. 139–173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7120253</ArticleId><ArticleId IdType="pubmed">15609503</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt N.J., Lennette E.H., Ho H.H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 1974;129:304–309.</Citation><ArticleIdList><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y., Bax A. Protein backbone and sidechain torsion angles predicted from NMR chemical shifts using artificial neural networks. J. Biomol. NMR. 2013;56:227–241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3701756</ArticleId><ArticleId IdType="pubmed">23728592</ArticleId></ArticleIdList></Reference><Reference><Citation>Smola M., Horova V., Boura E., Klima M. Structural basis for hijacking of the host ACBD3 protein by bovine and porcine enteroviruses and kobuviruses. Arch. Virol. 2020;165:355–366.</Citation><ArticleIdList><ArticleId IdType="pubmed">31845156</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T., Lewthwaite P., Perera D., Cardosa M.J., McMinn P., Ooi M.H. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010;10:778–790.</Citation><ArticleIdList><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>Teilum K., Kunze M.B.A., Erlendsson S., Kragelund B.B. (S)Pinning down protein interactions by NMR. Protein Sci. 2017;26:436–451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5326574</ArticleId><ArticleId IdType="pubmed">28019676</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Pang Z., Fan H., Tong Y. Advances in anti-EV-A71 drug development research. J. Adv. Res. 2023 S2090-1232(23)89-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">37001813</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao X., Lei X., Zhang Z., Ma Y., Qi J., Wu C., Xiao Y., Li L., He B., Wang J. Enterovirus 3A facilitates viral replication by promoting phosphatidylinositol 4-kinase IIIβ–ACBD3 interaction. J. Virol. 2017;91</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5599760</ArticleId><ArticleId IdType="pubmed">28701404</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H., Cowling B.J. Remaining challenges for prevention and control of hand, foot, and mouth disease. Lancet Child Adolesc. Health. 2019;3:373–374.</Citation><ArticleIdList><ArticleId IdType="pubmed">30885695</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu P., Ji W., Li D., Li Z., Chen Y., Dai B., Han S., Chen S., Jin Y., Duan G. Current status of hand-foot-and-mouth disease. J. Biomed. Sci. 2023;30:15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9951172</ArticleId><ArticleId IdType="pubmed">36829162</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>